Cleveland Clinic's Top 10 Medical Innovations For 2009
This article was originally published in The Gray Sheet
Executive Summary
1. Use of circulating tumor cell technology: A blood test assessing chemotherapy progress by measuring for cancer cells that have broken away from an existing tumor and entered the bloodstream.
You may also be interested in...
Synapse Biomedical Debuts Diaphragm Pacer, HDE-Cleared To Aid Breathing
Synapse Biomedical will pursue expanded approval of its diaphragm pacing system to facilitate breathing in patients with Lou Gehrig's disease after gaining a humanitarian device exemption June 17 for use by ventilator-dependent spinal cord injury patients, according to the company
US FDA Complete Response Letter Rates Vary With Sponsor Size
Pink Sheet infographic illustrates benefits of big pharma’s resources and experience.
Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise, but is there an appetite for another reorganization?